CNBC   |  July 24, 2014

Rush to tax inversions

Discussing whether there is a rush for companies to make tax inversions, with Dr. Ron Cohen, Acorda Therapeutics founder & CEO; CNBC contributor Bethany McLean; Ron Kruszewski, Stifel Financial Chairman, President & CEO; and Arthur Brooks, American Ent...

Share This:

Sorry, we do not have a transcript available for this video at this time.